問卷

TPIDB > Principal Investigator

Principal Investigator



更新時間:2025-12-01

謝正彥
  • Co-Principal Investigator
  • Clinical Trial Experience (year)

篩選

List

3Cases

2025-12-01 - 2033-05-05

Phase III

Not yet recruiting
FORAGER-2: A Phase 3, Randomized, Double-blind, Placebo-controlled Study Evaluating the Efficacy and Safety of Vepugratinib Combined With Enfortumab Vedotin and Pembrolizumab in Adults With Untreated Locally Advanced or Metastatic Urothelial Carcinoma With an FGFR3 Genetic Alteration
  • Condition/Disease

    Carcinoma, Transitional Cell、 Urinary Bladder Neoplasms 、Neoplasm Metastasis

  • Test Drug

    N/A

Participate Sites
10Sites

Recruiting5Sites

2026-03-01 - 2032-12-31

Phase II/III

Not yet recruiting
  • Condition/Disease

  • Test Drug

Participate Sites
5Sites

2025-12-08 - 2032-09-03

Phase III

Not yet recruiting
  • Condition/Disease

  • Test Drug

Participate Sites
5Sites

Recruiting5Sites